David Kirn is co-founder and CEO of 4D Molecular Therapeutics (4DMT), a company using directed evolution to invent new adeno-associated virus (AAV) vectors that are tailored to specific target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback